BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26261611)

  • 1. Prognostic correlation between MTA2 expression level and colorectal cancer.
    Ding W; Hu W; Yang H; Ying T; Tian Y
    Int J Clin Exp Pathol; 2015; 8(6):7173-80. PubMed ID: 26261611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of MTA2 and Ki-67 in hepatocellular carcinoma and their correlation with prognosis.
    Shi W; Hu J; Zhu S; Shen X; Zhang X; Yang C; Gao H; Zhang H
    Int J Clin Exp Pathol; 2015; 8(10):13083-9. PubMed ID: 26722504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
    Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
    Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of Rab5A predicts metastasis and poor prognosis in colorectal cancer patients.
    Yu MH; Luo Y; Qin SL; Zhong M
    Int J Clin Exp Pathol; 2015; 8(6):6974-80. PubMed ID: 26261586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of pyruvate kinase M2 in human colorectal cancer and its prognostic value.
    Cui R; Shi XY
    Int J Clin Exp Pathol; 2015; 8(9):11393-9. PubMed ID: 26617865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of phospho-mTOR kinase is abundant in colorectal cancer and associated with left-sided tumor localization.
    Melling N; Simon R; Izbicki JR; Terracciano LM; Bokemeyer C; Sauter G; Marx AH
    Int J Clin Exp Pathol; 2015; 8(6):7009-15. PubMed ID: 26261591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Rab27A expression indicates favorable prognosis in CRC.
    Shi C; Yang X; Ni Y; Hou N; Xu L; Zhan F; Zhu H; Xiong L; Chen P
    Diagn Pathol; 2015 Jun; 10():68. PubMed ID: 26070933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of metastasis-associated protein 2 is associated with hepatocellular carcinoma size and differentiation.
    Lee H; Ryu SH; Hong SS; Seo DD; Min HJ; Jang MK; Kwon HJ; Yu E; Chung YH; Kim KW
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1445-50. PubMed ID: 19702911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of COUP-TF II cooperated with negative Smad4 expression predicts poor prognosis in patients with colorectal cancer.
    Wang C; Zhou Y; Ruan R; Zheng M; Han W; Liao L
    Int J Clin Exp Pathol; 2015; 8(6):7112-21. PubMed ID: 26261604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of histone deacetylase 10 predicts poor prognosis of gastric cancer patients.
    Jin Z; Jiang W; Jiao F; Guo Z; Hu H; Wang L; Wang L
    Int J Clin Exp Pathol; 2014; 7(9):5872-9. PubMed ID: 25337229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of human epidermal growth factor receptor protein expression and colorectal cancer.
    Yang WJ; Shen XJ; Ma XX; Tan ZG; Song Y; Guo YT; Yuan M
    World J Gastroenterol; 2015 Jul; 21(28):8687-96. PubMed ID: 26229411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
    Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y
    Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of PAK-1 is an independent predictor of disease recurrence in colorectal carcinoma.
    Al-Maghrabi J; Emam E; Gomaa W; Al-Qaydy D; Al-Maghrabi B; Buhmeida A; Abuzenadah A; Al-Qahtani M; Al-Ahwal M
    Int J Clin Exp Pathol; 2015; 8(12):15895-902. PubMed ID: 26884861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer.
    Xu J; Liu Y; Wang X; Huang J; Zhu H; Hu Z; Wang D
    Int J Clin Exp Pathol; 2015; 8(3):2909-18. PubMed ID: 26045799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gab2 is a novel prognostic factor for colorectal cancer patients.
    Ding C; Luo J; Yu W; Gao S; Yang L; Chen C; Feng J
    Int J Clin Exp Pathol; 2015; 8(3):2779-86. PubMed ID: 26045784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of ANO9 in stage II and III colorectal carcinoma.
    Li C; Cai S; Wang X; Jiang Z
    Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer.
    Duncan TJ; Watson NF; Al-Attar AH; Scholefield JH; Durrant LG
    World J Surg Oncol; 2007 Mar; 5():31. PubMed ID: 17349047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha B-crystallin correlates with poor survival in colorectal cancer.
    Shi C; He Z; Hou N; Ni Y; Xiong L; Chen P
    Int J Clin Exp Pathol; 2014; 7(9):6056-63. PubMed ID: 25337251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of Y-box-binding protein 1 is associated with local recurrence and predicts poor outcome in patients with colorectal cancer.
    Yan X; Yan L; Zhou J; Liu S; Shan Z; Jiang C; Tian Y; Jin Z
    Int J Clin Exp Pathol; 2014; 7(12):8715-23. PubMed ID: 25674237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gremlin1 expression associates with serrated pathway and favourable prognosis in colorectal cancer.
    Pelli A; Väyrynen JP; Klintrup K; Mäkelä J; Mäkinen MJ; Tuomisto A; Karttunen TJ
    Histopathology; 2016 Nov; 69(5):831-838. PubMed ID: 27257976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.